News
Investors chronicle: 'Profit from artificial intelligence in neuroscience'
Published on investors chronicle: 22nd July, 2019 Author: Simon Thompson IXICO may be a small-cap London-based company well under the radar of investors, but it is highly regarded by pharmaceutical and biotechnology companies and huge corporations are increasingly awarding the company new contracts.
17-17 of 17 results